Stocks

The table gives an overview of all stocks, alphabetically sorted.
 AB INBEV ABI Jan 24, 2020 70.71 +1.03   
 ABO-Group ABO Jan 24, 2020 2.36 +6.31   
 Acacia Pharma Group Plc ACPH Jan 24, 2020 3.11 +5.07   
 Accentis S.A. ACCB Jan 24, 2020 0.05 -2.80   
 Ackermans & van Haaren NV ACKB Jan 24, 2020 148.20 +0.54   
 Aedifica SA AED Jan 24, 2020 122.20 +1.66   
 Ageas AGS Jan 24, 2020 51.50 +0.19   
 AGFA-Gevaert NV AGFB Jan 24, 2020 4.58 +0.13   
 AHOLD DEL AD Jan 24, 2020 22.45 +2.05   
 Antares Certificates ANT Jan 24, 2020 49.50 0.00   
 APERAM APAM Jan 24, 2020 26.78 +1.21   
 Argen X SE ARGX Jan 24, 2020 133.10 -1.92   
 Ascencio Sca ASC Jan 24, 2020 57.00 +0.35   
 ASIT biotech SA ASIT Jan 24, 2020 0.21 -0.71   
 Assicurazioni Generali SpA GEN Jan 24, 2020 18.10 +6.47   
 Atenor ATEB Jan 24, 2020 75.40 +0.80   
 AVANTIUM AVTX Jan 24, 2020 4.04 -1.71   
 Balta Group N.V. BALTA Jan 24, 2020 2.35 +1.29   
 Banco Bilbao Vizcaya Argentari BBV Jan 24, 2020 4.75 0.00   
 Banco Santander S.A. SANTA Jan 24, 2020 3.59 -0.95   
 Banimmo BANI Jan 24, 2020 3.44 -0.58   
 Banque Nationale de Belgique BNB Jan 24, 2020 2 350.00 +0.86   
 Barco NV BAR Jan 24, 2020 227.00 0.00   
 Basilix BAS Jan 24, 2020 15.52 0.00   
 Beaulieu Av Certificates BEAB Jan 24, 2020 89.74 +1.80   
 Befimmo SA BEFB Jan 24, 2020 54.40 +0.93   
 Bel20 BEL20 Jan 24, 2020 4 002.84 +0.62   
 Belreca - Belgian Resources an BELR Jan 24, 2020 105.00 0.00   
 Beluga BELU Jan 24, 2020 2.90 0.00   
 Biocartis Group NV BCART Jan 24, 2020 6.51 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK